IPAS770
Concessão de registro em designação
RPI 2728
18/04/2023
Voltar para busca
Dado oficial do INPI
COMBINEXT
Sabia que essa marca já está registrada no Brasil?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Registro de marca em vigor (Madri)Tipo: VerbalEscritório: Brasil
Snapshot rápido
COMBINEXT
ST13
BR500000501651471Classe
1, 5, 42
Pedido
501651471
Registro
501651471
Andamento no INPI
- Depósito06/08/21
- Publicação10/05/22
- Exame
- Deferimento18/10/22
- Concessão18/04/23
- Vigente06/08/31
Registro concedido em 18/04/2023 e em vigor até 06/08/2031, quando precisa ser renovado.
Proteção válida até:06/08/2031
Última movimentação publicada pelo INPI: 18/04/2023. Atualizamos a cada nova RPI, publicada semanalmente.
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação INPI
Registro de marca em vigor (Madri)
Tipo de processo
Pedido e registro
Eventos registrados
3
Atualização mais recente
18/04/2023
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
06/08/2021
Data de registro
18/04/2023
Data de expiração
06/08/2031
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Natureza
Madri
Produto/Serviço
Escritório responsável
Brasil
Tipo de titular
NÃO RESIDENTE
Localização do titular
US
Titulares e representantes
Titulares
COMBINEXT LLC
Representantes
Sem dados de representantes.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical compositions and preparations for environmental testing and research
Classe 5
Pharmaceutical composition for medical purposes for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disorderspharmaceutical composition for medical purposes for use in targeted pharmaceutical therapies for the treatment of pulmonary viral infectiondelivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of infectious diseasesdelivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of pulmonary viral infectiondrug delivery agents for medical purposes consisting of compositions that facilitate the delivery of a wide range of pharmaceutical based therapiesvaccinesvaccine preparationsmedical preparations for the treatment of infectious diseasespharmaceutical preparations and substances for the treatment of infectious diseases and disorderspharmaceutical preparations and substanceschemical preparations for the treatment of diseaseschemical preparations for pharmaceutical purposeschemical preparations for medical purposespharmaceutical compositions and preparations containing lipophilic stains for scientific testing and research, biological testing and research, diagnostic testing and research, and environmental testing and researchpharmaceutical compositions and preparations for the detection of pathogenspharmaceutical compositions and preparations containing lipophilic stains for the detection of pathogenspharmaceutical compositions and preparations for environmental testing provided as part of a kitkits for environmental use comprised of pharmaceutical compositions and preparations containing lipophilic stainspharmaceutical compositions and preparations for the detection of pathogens through use of lateral flow assays, immunochemistry, affinity chromatography, microfluidics, or nanotechnology
Classe 42
Research services relating to treatments for infectious diseasesresearch services related to the development of vaccinesresearch and development of drug delivery platforms for use in the treatment of infectious diseases and disordersresearch and development of compositions for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disordersscientific and technological services, namely, scientific analysis in the field of research and development relating to compositions for use in the treatment of infectious diseasesscientific and technological services, namely, research and development relating to compositions for use in the treatment of infectious diseasesscientific and technological services, namely, research and development relating to compositions for use in the treatment of pulmonary viral infectionsdesign and development of compositions for use in the treatment of infectious diseasesconsulting services relating to the design and development of compositions for use in the treatment of infectious diseasesconsulting services relating to the design and development of targeted pharmaceutical therapiesresearch services relating to the detection of pathogensresearch and development of compositions and preparations for use in the detection of pathogensscientific and technological services, namely, scientific analysis in the field of research and development relating to compositions and preparations for use in the detection of pathogensscientific and technological services, namely, research and development relating to compositions and preparations for use in the detection of pathogensdesign and development of compositions for use in the detection of pathogensconsulting services relating to the design and development of compositions and preparations for use in the detection of pathogens
Publicações
Histórico de despachos e eventos da marca no INPI.
3 publicações encontradas
IPAS768
Deferimento de designação
RPI 2702
18/10/2022
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2679
10/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COMBINEXT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.